Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-01-07 @ 9:30 AM
Study NCT ID:
NCT02747004
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-20
First Post:
2016-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-19
First Submit QC Date:
None
Study First Post Date:
2016-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-14
Results First Submit QC Date:
None
Results First Post Date:
2019-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-04-20
Last Update Post Date Type:
ACTUAL